Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

AI blind-sweep obstetric ultrasound by non-specialists in rural DRC

Official title: Diagnostic Accuracy and Implementation Feasibility of AI-Assisted Blind Ultrasound Sweep (SPAQ E-con AI) for Antenatal Screening by Non-Specialist Health Workers in Rural Democratic Republic of the Congo

Run by SOIK Corporation Sarl · NCT07677670 · Data updated 2026-11-12

Researchers test an AI-assisted blind-sweep ultrasound to screen pregnant women in rural Democratic Republic of Congo, using non-specialist health workers.

More Maternal Health trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment3000 (estimated)
SponsorSOIK Corporation Sarl
Industry-sponsored
Locations1 site (Kenge, Kwango)
StatusRecruiting
StartedJune 19, 2026
Main results expectedDecember 31, 2026
Study endsJune 13, 2027
Registry record updatedSeptember 15, 2026
Trial IDNCT07677670 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women aged 18 years or older presenting for routine antenatal care at participating facilities in Kenge, Kwango province, including those reachable via village outreach.

Probably not a fit

Women with planned relocation outside Kwango or unable to provide consent may not benefit from the study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the diagnostic accuracy and feasibility of a AI-assisted blind-sweep obstetric ultrasound (SPAQ E-con AI) operated by trained non-specialist health workers during antenatal screening in rural DRC. It follows a Hybrid Type 1 design to assess both effectiveness and implementation, with model updates planned after interim analyses. Primary outcomes focus on gestational age estimation accuracy and AI confidence calibration, using manual ultrasound measurements as the reference standard. Enrollment targets include about 1,380 participants across two batches, with a ceiling of 3,000 and potential early stop if predefined criteria are met. The study is conducted at up to six facilities in the Kenge health zone, Kwango province, plus village outreach sites, and includes sub-cohorts for early and late gestational ages.

Why it matters

Potential benefit: If successful, this approach could enable accurate antenatal screening in resource-limited settings using non-specialist workers and AI-augmented imaging.

How similar studies have gone: Prior studies in AI-guided point-of-care ultrasound have shown promise in various settings, but this specific blind-sweep approach with non-specialist operators in rural Africa is relatively novel and under evaluation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women aged 18 years or older
* Identified at a participating facility routine ANC visit or RECO village outreach within the Kenge health zone catchment
* Written informed consent obtained

Exclusion Criteria:

* Emergency presentation
* Duplicate re-registration of an already-enrolled woman
* Lacking capacity to consent
* Planned relocation outside Kwango province during the study period
* Refusal of consent

Where it's running

  • Centre de Sante CBCO
    Kenge, Kwango, Democratic Republic of the Congo
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.